Title : Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence.

Pub. Date : 2018 Mar

PMID : 28857070






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The current study is the first investigation of the effects of a KOP-r-antagonist in cocaine-dependent persons in comparison with normal volunteers. Cocaine opioid receptor kappa 1 Homo sapiens